GlassScriptPhysician profile
Carolina Cabrera
NPI 1396451159
$6,010.05
in general payments reported to CMS, 2019-2025
17 companies · $2,036 in 2025
The $2,036 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,344 · 2024: $2,630 · 2025: $2,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,986 · Education: $23.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,986.33 |
| Education | $23.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,750.42 | 2023-2025 | |
| Arcutis Biotherapeutics, INC. | $479.52 | 2024-2025 | Zoryve |
| Janssen Biotech, INC. | $473.86 | 2023-2025 | Tremfya |
| Genzyme Corporation | $401.33 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $369.30 | 2023-2025 | Sotyktu |
| Ucb, INC. | $330.11 | 2024-2025 | Bimzelx |
| Incyte Corporation | $326.98 | 2023-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $320.45 | 2023-2025 | Winlevi, Ilumya |
| Novartis Pharmaceuticals Corporation | $267.45 | 2024-2025 | |
| Lilly USA, LLC | $253.56 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Pfizer INC. | $240.02 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $208.56 | 2023-2024 | Dupixent |
| Dermavant Sciences, INC. | $208.43 | 2023-2024 | Vtama |
| Galderma Laboratories, L.P. | $148.68 | 2024-2025 | Nemluvio |
| Mayne Pharma Commercial LLC | $130.23 | 2023-2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $74.28 | 2024-2025 | Otezla, Otezla |
| Verrica Pharmaceuticals INC. | $26.87 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolina Cabrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.